Soleil Securities Downgrades Varian Medical Systems (VAR) to Hold
More News related to VAR
- Soleil Securities Upgrades Varian Medical Systems (VAR) to Buy; Raises FY10-11 Estimates & PT
- Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal
- Varian Medical (VAR) Posts Q4 EPS of $0.78, Beats by 4c; Guides
- Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2009
- Varian Medical Systems to Exhibit Technology Enhancements Designed to Improve Speed and Precision of Radiotherapy at ASTRO 2009
Soleil Securities downgrades Varian Medical Systems (NYSE: VAR) from Buy to Hold with a $35 price target, citing increasing risk from declining reimbursement rates.
The firm said, "With preliminary 2010 Medicare Physician Fee Schedule increasing the medical equipment utilization rate from 50% to 90%, we believe that some free-standing radiation oncology centers might balk at purchasing new equipment--in fact, we confirmed with management that ~25-30% of VAR's U.S. business is levered to free-standing centers."
Related Categories
DowngradesStocks Mentioned
-0.23Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
